Evidence map›Paper›PMID 26956521›Full record

ArticleJournal of translational medicine2016

Analysis of cellular and humoral immune responses against cytomegalovirus in patients with autoimmune Addison's disease.

Kine Edvardsen, Alexander Hellesen, Eystein S Husebye, Eirik Bratland

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kine EdvardsenDepartment of Clinical Science, University of Bergen, Laboratory Building, 8th floor, 5021, Bergen, Norway. kine.edvardsen@uib.no.
Alexander HellesenDepartment of Clinical Science, University of Bergen, Laboratory Building, 8th floor, 5021, Bergen, Norway. Richard.Hellesen@k2.uib.no.
Eystein S HusebyeDepartment of Clinical Science, University of Bergen, Laboratory Building, 8th floor, 5021, Bergen, Norway. eystein.sverre.husebye@helse-bergen.no.
Eirik BratlandDepartment of Clinical Science, University of Bergen, Laboratory Building, 8th floor, 5021, Bergen, Norway. Eirik.Bratland@uib.no.
University of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutoimmune Addison's disease (AAD) is caused by multiple genetic and environmental factors. Variants of genes encoding immunologically important proteins such as the HLA molecules are strongly associated with AAD, but any environmental risk factors have yet to be defined. We hypothesized that primary or reactivating infections with cytomegalovirus (CMV) could represent an environmental risk factor in AAD, and that CMV specific CD8(+) T cell responses may be dysregulated, possibly leading to a suboptimal control of CMV. In particular, the objective was to assess the HLA-B8 restricted CD8(+) T cell response to CMV since this HLA class I variant is a genetic risk factor for AAD.

methodsTo examine the CD8(+) T cell response in detail, we analyzed the HLA-A2 and HLA-B8 restricted responses in AAD patients and healthy controls seropositive for CMV antibodies using HLA multimer technology, IFN-γ ELISpot and a CD107a based degranulation assay.

resultsNo differences between patients and controls were found in functions or frequencies of CMV-specific T cells, regardless if the analyses were performed ex vivo or after in vitro stimulation and expansion. However, individual patients showed signs of reactivating CMV infection correlating with poor CD8(+) T cell responses to the virus, and a concomitant upregulation of interferon regulated genes in peripheral blood cells. Several recently diagnosed AAD patients also showed serological signs of ongoing primary CMV infection.

conclusionsCMV infection does not appear to be a major environmental risk factor in AAD, but may represent a precipitating factor in individual patients.

Indexed as

Immunity, CellularImmunity, HumoralAddison DiseaseAdultAntibodies, ViralCase-Control StudiesCD8-Positive T-LymphocytesCell DegranulationCytomegalovirusCytomegalovirus InfectionsExocytosisHumansInterferon-gammaLymphocyte CountPeptidesSpecies SpecificityAntibodies, ViralInterferon-gammaPeptides

Identifiers

PMID26956521
PMCPMC4784442
OpenAlexW2294058008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.